Showing results (901-910 of 1,351) with videos related to
Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|July 28, 2018
Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics of Alicapistat, a Selective Inhibitor of Human Calpains 1 and 2 for the Treatment of Alzheimer Disease: An Overview of Phase 1 StudiesHoi-Kei Lon, Nuno Mendonca, Sandra Goss, et al.Clinical Pharmacology in Drug Development|July 25, 2018
Oral Bioavailability and Pharmacokinetics of Nonanimal Chondroitin Sulfate and Its Constituents in Healthy Male VolunteersNicola Volpi, Veronica Mantovani, Fabio Galeotti, et al.Clinical Pharmacology in Drug Development|September 1, 2018
Characterizing the Sources of Pharmacokinetic Variability for TAK-117 (Serabelisib), an Investigational Phosphoinositide 3-Kinase Alpha Inhibitor: A Clinical Biopharmaceutics Study to Inform Development StrategyChirag G Patel, Lakshmi Rangachari, Mark Patti, et al.Clinical Pharmacology in Drug Development|August 26, 2018
Assessment of the Effects of Age and Renal Function on Pharmacokinetics of Bazedoxifene in Postmenopausal WomenWilliam McKeand, James Ermer, Joan Korth-BradleyClinical Pharmacology in Drug Development|August 29, 2018
Pharmacokinetics and Comparative Bioavailability of a Levothyroxine Sodium Oral Solution and Soft CapsuleMario Tanguay, Johanne Girard, Claudia Scarsi, et al.Clinical Pharmacology in Drug Development|June 6, 2017
Effects of a Nutritional Protein-Rich Drink on the Pharmacokinetics of Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide, and Tenofovir Compared With a Standard Meal in Healthy Japanese Male SubjectsHiroyuki Yamada, Ippei Ikushima, Takanori Nemoto, et al.Clinical Pharmacology in Drug Development|June 20, 2017
Effect of Food Intake on the Pharmacokinetics of a Novel Methylphenidate Extended-Release Oral Suspension for Attention Deficit Hyperactivity DisorderFloyd R Sallee, Donna R Palumbo, Richat Abbas, et al.Clinical Pharmacology in Drug Development|June 10, 2017
Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of an Omega-3-Carboxylic Acid Formulation in Healthy Male Japanese Subjects: A Phase 1 Single-Blind, Randomized, Placebo-Controlled TrialYoshinori Noda, Catarina Nilsson, Hitoshi Shimada, et al.Clinical Pharmacology in Drug Development|April 21, 2018
Bioequivalence of Canakinumab Injected Subcutaneously via an Autoinjector Device or a Prefilled Safety Syringe Device in Healthy SubjectsSivaNaga S Anumolu, Sam Lindgren, Janardhana Vemula, et al.Clinical Pharmacology in Drug Development|April 24, 2018
A Study of the Potential Interaction Between Bazedoxifene and Atorvastatin in Healthy Postmenopausal WomenWilliam McKeand, Susan Baird-Bellaire, James Ermer, et al.Pageof 136